Evidence map›Paper›PMID 19837945›Full record

ArticleMolecular endocrinology (Baltimore, Md.)2009

Role of phospholipase D in parathyroid hormone type 1 receptor signaling and trafficking.

José Luis Garrido, David Wheeler, Luis Leiva Vega, Peter A Friedman, Guillermo Romero

Abstract read
In one paragraph

Article in Molecular endocrinology (Baltimore, Md.), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. GPCR Signaling and Trafficking: The Long and Short of It.Trends in endocrinology and metabolism: TEM · 2017
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Non-canonical signaling of the PTH receptor.Trends in pharmacological sciences · 2012
    Review
  11. Ubiquitination-deubiquitination balance dictates ligand-stimulated PTHR sorting.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2011
    Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

José Luis GarridoDepartment of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pennsylvania 15261, USA.
David Wheeler
Luis Leiva Vega
Peter A Friedman
Guillermo Romero
University of Pittsburgh · US

Funding

PTH Receptor: Posttranslational Modification and Recycling in BoneR01DK054171 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI FRIEDMAN, PETER A · 1998 to 2015
$6.0M
PREDOCTORAL TRAINING IN PHARMACOLOGICAL SCIENCEST32GM008424 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI PAGANO, PATRICK J · 1994 to 2019
$3.4M
Effects of NHERF1 expression on PTH1R dynamics and function in polarized cellsF30DK083211 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI WHEELER, DAVID SHERWOOD · 2008 to 2012
$170k
NIDDK NIH HHS DK-083211NIDDK NIH HHS DK-54171NIDDK NIH HHS F30 DK083211NIDDK NIH HHS R01 DK054171NIGMS NIH HHS GM-08424NIGMS NIH HHS T32 GM008424
6 · The paper itself

Abstract

The role of phospholipase D (PLD) in the regulation of the traffic of the PTH type 1 receptor (PTH1R) was studied in Chinese hamster ovary cells stably transfected with a human PTH1R (CHO-R3) and in rat osteosarcoma 17/2.8 (ROS) cells. PTH(1-34) increased total PLD activity by 3-fold in CHO-R3 cells and by 2-fold in ROS cells. Overexpression of wild-type (WT) PLD1 and WT-PLD2 increased basal PLD activity in CHO-R3 but not in ROS cells. Ligand-stimulated PLD activity greatly increased in CHO-R3 cells transfected with WT-PLD1 and WT-PLD2. However, only WT-PLD2 expression increased PTH-dependent PLD activity in ROS cells. Expression of the catalytically inactive mutants R898K-PLD1 (DN-PLD1) and R758K-PLD2 (DN-PLD2) inhibited ligand-dependent PLD activity in both cell lines. PTH(1-34) induced internalization of the PTH1R with a concomitant increase in the colocalization of the receptor with PLD1 in intracellular vesicles and in a perinuclear, ADP ribosylation factor-1-positive compartment. The distribution of PLD1 and PLD2 remained unaltered after PTH treatment. Expression of DN-PLD1 had a small effect on endocytosis of the PTH1R; however, DN-PLD1 prevented accumulation of the PTH1R in the perinuclear compartment. Expression of DN-PLD2 significantly retarded ligand-induced PTH1R internalization in both cell lines. The differential effects of PLD1 and PLD2 on receptor traffic were confirmed using isoform-specific short hairpin RNA constructs. We conclude that PLD1 and PLD2 play distinct roles in regulating PTH1R traffic; PLD2 primarily regulates endocytosis, whereas PLD1 regulates receptor internalization and intracellular receptor traffic.

Indexed as

AnimalsCell Line, TumorCHO CellsCricetinaeCricetulusFlow CytometryHumansImmunohistochemistryMicroscopy, ConfocalParathyroid HormonePhospholipase DRatsReceptor, Parathyroid Hormone, Type 1Reverse Transcriptase Polymerase Chain ReactionSignal TransductionParathyroid HormonePhospholipase Dphospholipase D1phospholipase D2Receptor, Parathyroid Hormone, Type 1

Identifiers

PMID19837945
PMCPMC2796153
OpenAlexW2049131759

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.